A major obstacle to obtaining more detailed insights into the diversity of phenotypic and molecular changes occurring in colon cancer cells is the lack of low-passage colon cancer cell lines, which would still closely reflect the phenotype of the colon cancer cells in vivo. Here, we characterize eight novel, low passage number human colon carcinoma cell lines, originating from colorectal cancers extensively characterized in the clinics. All cell lines closely resemble the original tumors with respect to phenotype, markers and detectable genetic changes. Cell morphology and marker expression is highly variable, ranging from fully polarized cells correctly expressing all basolateral epithelial markers, to cells with mesenchymal characteristics and a complete loss of polarity due to delocalization or loss of junction complex proteins. The alterations in phenotype and epithelial marker expression correspond to changes already detectable in the primary tumor in vivo. Seven of the cell lines show chromosomal instability, while one cell line is characterized by microsatellite instability. p53 associated with K-ras mutations were detected in three cell lines. Hitherto nondescribed E-cadherin mutations were found at both alleles in one cell line whereas in another cell line the E-cadherin protein was down-regulated. A stabilizing b-catenin mutation (S45F) appears in the same cell line that carried the mutated E-cadherin gene. Six cell lines carried APC mutations, which in five of the lines led to an activated bcatenin/Tcf/LEF signaling pathway. In accordance with b-catenin/Tcf/LEF activation, the cell lines show increased migration and invasiveness. Our results show that the characterized, low-passage cell lines mirror the diversity of the individual tumors from which they were derived. Through molecular analyses of these cell lines we demonstrate that tumorgenicity events are much more diverse in human colon cancer than expected, despite the common origin of the tumors from a small patient group with similar tumor grading and clinical prognosis.
Introduction
In general colorectal tumors develop through adenomas graded by increasing de-differentiation exemplified by the adenoma-carcinoma sequence (Handford, 1890; Kinzler and Vogelstein, 1996; Nagase et al., 1996) . In colorectal cancers, two types of genomic instabilities have been observed: microsatellite instability (MIN) and chromosomal instability (CIN). As a result of this genetic instability, fully developed CIN malignancies have a unique aneuploid karyotype (Nowell, 1976) . Cancers gain malignant properties by the amplification of oncogenes and functional inactivation of tumor suppressor genes, providing the cancer cells with a selective growth advantage (Cahill et al., 1999; Hanahan and Weinberg, 2000; Klein, 1998; Lengauer et al., 1998) . Growth of most colorectal cancers starts with mutations in the adenomatous polyposis coli (APC) tumor suppressor gene, which truncate and functionally inactivate the respective APC protein (Kinzler and Vogelstein, 1996; . The intact APC protein contains multiple b-catenin and axin binding sites in its central part and nuclear export signals both at its N-and C-terminal ends. According to a current model, APC binds b-catenin, exports it from the nucleus (Henderson, 2000; Rosin-Arbesfeld et al., 2000) and targets it for phosphorylation within a protein complex consisting of APC, axin and glycogen synthase kinase 3b (GSK-3b). Phosphorylated bcatenin is then ubiquitinated and degraded in the proteasome (Bienz and Clevers, 2000; . APC mutations in colorectal tumors mostly represent deletions in the mutation cluster region (MCR) located in the central part of the protein, abolishing not only bcatenin and axin binding domains but also preventing nuclear export (Rosin-Arbesfeld et al., 2000) . As bcatenin accumulates in the nucleus, it binds to the lymphoid enhancer factor 1 (LEF-1) or T-cell factor 4 (Tcf-4) and functions as a transcriptional coactivator by altering DNA architecture and thereby the local environment of specific promotors (Prieve and Waterman, 1999) . The extent of the loss of b-catenin bindingsites in APC is proportional to the increased b-catenin/ LEF-1/Tcf-4 transcriptional activation in the Wnt pathway and, consequently, cell proliferation.
In colorectal cancer, the K-ras oncogene is generally amplified or mutated together with a wide array of mutations in other oncogenes and tumor suppressor genes. Expression levels of activated Ras were also correlated with tumorigenicity in several human cell models based on primary cells (Elenbaas et al., 2001; Hahn et al., 1999) . In addition, spontaneous amplification of c-Myc was observed. c-Myc is a potent activator of cell proliferation preventing exit from the cell cycle through induction of Cyclins D1 and D2 (Dang, 1999; Henriksson and Luscher, 1996) . D-type cyclins bind to CDK4 and CDK6 to induce cyclin A and cyclin E, which bind to CDK2 to increase G1-S transition. c-Myc has a b-catenin binding site in its promoter (He et al., 1998) and thus is upregulated by the Wnt pathway. This overexpression causes c-Myc binding to specific DNA sequences in the cyclin D2 promoter and activates its transcription (Bouchard et al., 1999) . Wnt signaling may also directly upregulate cyclin D1, since the cyclin D1 promoter contains LEF-1 binding sites and was identified as a direct target of the Wnt pathway (Shtutman et al., 1999; Tetsu and McCormick, 1999) .
A hallmark of epithelial cancers is their progressive loss of epithelial polarity and tissue organization, as indicated by redistribution or loss of various epithelial markers. The frequent loss of cell adhesion in epithelial cancers suggests that E-cadherin function may be responsible for the block in the transition from adenoma to carcinoma, preventing local invasiveness (Perl et al., 1998) . In general, de-regulation or mislocalization of cell adhesion molecules and their regulators, such as E-cadherin and bcatenin, correlate with loss of polarity, de-differentiation, invasive tumor growth and metastasis (Hsu et al., 2000; Soroceanu et al., 2001; Wijnhoven et al., 2000) .
Despite significant progress in identifying the molecular changes contributing to the malignant phenotype of colon cancer cells (for review see (Hanahan and Weinberg, 2000; Kinzler and Vogelstein, 1996; Lengauer et al., 1998) ), a more detailed understanding how colon carcinoma cells differ from their normal counterparts is impeded by the lack of cell systems closely reflecting the properties of the primary tumor cells. A few low passage cell lines with such properties have recently been derived from primary intestinal epithelial cells (Panja, 2000) , gastric cancers (Oh et al., 1999; Yokozaki, 2000) and human lung cancers (Wistuba et al., 1999) . However, cell culture models closely resembling their parental primary human colon cancers have not been established. The need for such models is obvious since clinicians face a diversity of colon cancers where each tumor must be regarded as unique. In an effort to mimic this situation in homogenous cell culture models, a collection of low passage number (PN) cell lines was established. Eight lines with diverse, typical phenotypes were characterized in detail for epithelial polarity and respective markers, presence of mutations frequently occurring in colon tumors (APC, K-Ras, p53, E-cadherin, b-catenin) and functional activity of the Wnt/b-catenin pathway. These novel cell lines did not only mirror the features of the original, individual, diverse tumors they were derived from, they also reflected different stages of tumors occurring in the same organ and their metastases. Each of these eight colon carcinoma cell lines was shown to possess distinct combinations of unique oncogenes and tumor supressor mutations. Identical mutations were found in the respective parental tumors. Our results demonstrate an unexpected diversity of oncogenic and tumor-suppressive mutations in a small sample of human colon carcinomas, and establish that low-passage colon carcinoma lines may be important tools to characterize molecular events in generation and progression of colon carcinomas.
Results
The isolated, low passage number cell lines show widely different phenotypes Table 1 shows an initial description of the eight cell lines analysed, summarizing patient histories, tumor localization, tumor grading, genetic stability, karyotype and cellular phenotype. It should be emphasized that COGA-5* and COGA-5L* originate from the same patient. COGA-5* comes from the primary tumor in the flexura coli dextra whereas COGA-5L* was grown out from the respective lymph node metastasis.
First we performed detailed karyotyping of all the lines. All cell lines but one (COGA-1) showed gain of chromosomes, with hyperdiploidy (COGA-3, COGA-5, COGA-12), near triploidy (COGA-2, COGA-5L, COGA-10) and near tetraploidy (COGA-8). They also included structural rearrangements, which were analysed more in detail using SKY in case of COGA-8, COGA-10 and COGA-12. A representative SKY metaphase is shown in Figure 1a -c. The refined SKY-karyotyping is shown in Figure 1d and summarized in Table 1 . COGA1 was derived from a high-grade mucinous carcinoma of the coecum. This tumor showed MIN in seven out of 11 satellites investigated. Instability was seen for D2S123, BAT25, BAT26, D3S1611S, D13S153, D18S34, and TP53. Based on the MIN, the clinical and familial history of the patient and tumor localization and differentiation, this tumor can be classified as hereditary non-polyposis colon cancer (Lynch II).
Normal colon epithelium is strictly polarized while during tumor progression and metastasis the respective tumor cells are known to exhibit a remarkable phenotypic plasticity. We therefore analysed potential alterations of the epithelial phenotype (e.g. towards a mesenchymal phenotype) in the individual cell lines. With the possible exception of COGA-1, none of the eight cell lines in this study grew strictly in monolayers. Even the lines with an epithelial-like morphology, after first forming polarized islets on filters, showed a tendency to pile up to a different extent on the top Functional characterization of low passage number colon carcinoma cells B Vé csey-Semjén et al of the first cell layer (COGA-5, COGA-10; Table 1 ). Cells in the 'piled-up' category (COGA-5L, COGA-8, COGA-12) grew preferentially in multilayers. COGA-5L cells formed almost round, ball-like clumps on top of the first, support-attached cell layer while COGA-12 cells flattened out into thin monolayers around a central, multilayered aggregate, surrounding a cavity. In contrast, COGA-8 cells closely resembled adherent, mesenchymal cells (Table 1) . They had lost cell-cell adhesion, developed extended filopodia and migrated over each other to pile up into multilayers. Cells of the third category (COGA-2; COGA-3) showed a rounded up morphology and loosely attached to the support without forming cell-cell contacts. Rather, they aggregated into strand-or cord-like three-dimensional structures in the growth medium (Table 1) . When grown on a Biocoat poly-L-lysine coated support, the COGA-3 cells flattened out, elongated and showed a front-end back-end polarity typical of mesenchymal cells. The other cell lines were not morphologically influenced by the same coated support and none of the cell lines exhibited any morphological changes when cultured on collagen type I-, fibronectin-or laminin coated filter supports.
Subcellular mislocalization of junctional proteins
The multiple, but distinct alterations in morphology detected in the various cell lines prompted us to address whether different junctional proteins were expressed and/or properly localized in these cells, and whether some of the non-epithelial cells would show aspects of epithelial-mesenchymal transition (EMT), characterized by the synchronous loss of epithelial markers (E-cadherin, ZO-1) and gain of mesenchymal markers (vimentin, fibronectin) (Oft et al., 1996; Reichmann, 1994) . The presence and relative expression levels of EMT marker proteins were analysed by immunoblotting of whole cell lysates. Vimentin was found at very low but still clearly detectable levels in two cell lines: the lymph-node metastasis COGA-5L and in the liver metastasis COGA-10 ( Figure 2 ). Interestingly, vimentin was undetectable in the parental, primary tumor (COGA-5) despite the partial loss of a true epithelial phenotype in the latter. The highest levels of fibronectin were observed in the COGA-5L cells, expressing also vimentin (Figure 2 ). Unexpectedly, Caco 2 cells, used in our experiments as a negative control, had elevated levels of fibronectin when compared to the low passage-number colon carcinoma cell lines (Figure 2 ). This may be due to the fact, that despite their polarized morphology, Caco 2 cells are derived from a colon carcinoma and/or their rather high number of population doublings (PN 63). Biochemical detection of fibronectin in the positive cell lines could be confirmed by immunofluorescence analysis (data not shown). Surprisingly, no vimentin and only very low levels of fibronectin were expressed in the COGA-8 cells that seemed to display a mesenchymal morphology. Neither was the cell motility marker protein N-cadherin (Hsu et al., 2000) found at elevated levels in these cells (data not shown). The combination of severe loss of epithelial morphology and expression of mesenchymal markers in some of the cell lines rendered it necessary to ensure an epithelial origin in all cell lines tested. The corresponding general epithelial marker proteins Cytokeratin 8, 18 and 20 were analysed by immunofluorescence (IF) and were found uniformly expressed in all cell lines (data not shown), confirming that all cell lines originated from epithelia. We then analysed the cell lines for expression of marker proteins for the three different types of junctions typical for epithelial cells (for summary see Table 2 ). Connexin-43 is an integral gap junction protein, responsible for cytoplasmic connectivity. Immunofluorescence analysis of connexin-43 expression revealed that it was localized to perinuclear vesicles in COGA-8 and COGA-10 cells (data not shown). In cell lines COGA-5, COGA-5L and COGA-12, connexin-43 was detected not only in the cell membranes but also in the cytoplasm. In the rounded-up COGA-2 and COGA-3 cell lines connexin-43 was observed exclusively in the cytoplasm. The only cell line with an exclusive and correct plasma membrane localization of connexin-43 was the wellpolarized MIN cell line COGA-1.
The proteins ZO-1 and occludin, critical components of tight junctions, were analysed next (summarized in Table 2 ). ZO-1 and Occludin were observed not only in the membrane but also in the cytoplasm of half of the cell lines (COGA-2, COGA-3, COGA-8 and COGA-10). ZO-1 was detected in considerable concentrations in the nuclei of COGA-8 cells (see Table 2 ). In other cell lines (COGA-5, COGA-5L) both proteins retained their membrane-associated localization, but were distributed all over the plasma membrane, indicating possible loss of functional integrity of tight junctions in these cells as well.
Finally, we characterized adherens junction complexes, the major marker of which is E-cadherin. E-cadherin connects neighboring cells via its N-terminal end and interacts with the actin cytoskeleton through catenins bound to its cytoplasmic tail. Confocal microscopy analysis of the COGA-5 cells grown on filters revealed highly polarized cells (Figure 3a) in which E-cadherin (green) and b-catenin (red) co-localized in the lateral plasma membrane. In piled-up cells of the COGA-5L and COGA-12 cell lines E-cadherin and b-catenin were detected evenly distributed at the outer cell membrane (Figure 3b,d) . In COGA-10 cells (Figure 3c ), b-catenin accumulated in nuclei, though it could be also seen in the plasma membrane unevenly distributed in patches and co-localizing with E-cadherin. The intracellular localization of plakoglobin in the COGA-10 cells was similar to b-catenin and mainly nuclear (data not shown).
Loss/redistribution of epithelial markers in the COGA cell lines corresponds to respective expression patterns in the parental tumor tissues
Next we compared E-cadherin and b-catenin expression and localization in the cultured cell lines (confocal immunofluorescence microscopy) with the primary tumors they were derived from (immunohistological analysis). Tumor-1, the tumor tissue from which COGA-1 cells originated, displayed a relatively well differentiated intestinal tissue (Figure 4a , upper row). E-cadherin, detected by HECD-1 antibodies, was seen properly localized at the cell-cell borders, as was bcatenin ( Figure 4a , upper panels). COGA-1 cells, when grown on filters and stained with the same antibodies, showed correct localization of both E-cadherin and bcatenin to the lateral membrane of the polarized cells (see confocal image in Figure 4a , bottom panels).
In contrast, the staining of tumor-2 tissue, corresponding to the rounded, highly abnormal COGA-2 cells, showed all signs of a poorly differentiated carcinoma, including the presence of signet-ring cells as a marker for strong dedifferentiation. Tumor-2 was negative for E-cadherin, while b-catenin was localized both in the cytoplasm and nucleus (Figure 4b , upper panels). Interestingly, the corresponding COGA-2 cells expressed only trace amounts of E-cadherin as detected with the AEC antibody, visible as dots or short rodlike structures in the nuclei, while no E-cadherin was detected on the plasma membrane, revealing the total absence of adherens junctions (Figure 4b , bottom A similar concordance of morphology and marker expression was found between tumor-3 and cultured COGA-3 cells, which were derived from this tumor. The COGA-3 cells displayed a rounded morphology but in contrast to COGA-2 cells, exhibited an unpolarized, adherent morphology on poly-L-lysinecoated surfaces. In tumor-3, the tumor tissue was more differentiated than in tumor-2 and no signet-ring-cells were found. Although tumor-3 was negative for Ecadherin when stained with HECD-1 antibodies ( Figure  4c , upper left panel, insert), AEC antibodies detected nuclear E-cadherin ( Figure 4c , upper left panel). This indicated that the cytoplasmic tail of E-cadherin was still present, though mislocalized, and at low levels. Similarly, E-cadherin had a nuclear localization in the COGA-3 cells, visible as large aggregates and punctuate or rod-shaped structures ( Figure 4c , bottom left panel). Also, b-catenin was detected as nuclear as well as cytoplasmic in both tumor-3 and the corresponding COGA-3 cells ( Figure 4c , top/bottom right panels).
Finally we analysed COGA-8 cells, displaying mesenchymal morphology, and the corresponding tissue of tumor-8. The cells making up tumor-8 tissue clearly displayed a dedifferentiated, elongated and fibroblastic morphology. While E-cadherin appeared to be localized both at cell-cell borders and in the cytoplasm, b-catenin seemed to be mainly in the cytoplasm of tumor cells (Figure 4d , upper right panel). Confocal scanning microscopy of COGA-8 cells showed both adherens junction proteins mainly in the cytoplasm, forming punctuate aggregates (Figure 3d , bottom panels). Due to the flat, mesenchymal morphology of these cells on plastic, residual membrane localization of E-cadherin could be detected only by confocal microscopy.
In conclusion, both morphology and expression/ localization of E-cadherin and b-catenin to specific cellular compartments correlated excellently in primary colon carcinoma tissue and low PN carcinoma cell lines derived from this tissue.
Highly different levels of adherens junction proteins expressed in the tumor cell lines
To obtain insight also into the expression levels of the different adherens junction proteins, we performed Western blot analysis of whole cell extracts prepared from the different cultured colon carcinoma cell lines. We compared the signal intensity of specific protein bands observed in the colon cancer cell lines to those in Caco 2 cells, employed as a 'polarized', negative control. As 'unpolarized', positive control, SW 480 carcinoma cells were used, lacking E-cadherin expression as previously reported (Stewart and Nelson, 1997) .
In the two rounded-up cell lines COGA-2 and COGA-3 full length E-cadherin was absent while expressed at similar levels in the other cell lines ( Figure  5 ). We observed elevated levels of b-catenin in the cell lysates of COGA-5L, COGA-8, COGA-10 and COGA-12 cells ( Figure 5 ). In contrast, COGA-3 cells expressed b-catenin at strongly reduced levels. acatenin was detected only at very low levels in COGA-2 cells and was completely absent in COGA-3 cells, indicating disintegration of the adherens junction protein complex in these cells ( Figure 5 ). Plakoglobin or g-catenin, which can replace b-catenin in the adherens junctions, was present in all cell lines and at slightly elevated levels in COGA-5L and COGA-12 cells when compared to Caco 2 cells, and at lower levels in COGA-3 cells ( Figure 5 ). p120 binds directly to the membrane juxtaposed region of E-cadherin. Previous analysis in different cell types of two p120 isoforms, arising by alternative splicing causing loss of the start codon and 101 amino acids in the shorter p120-2 isoform, (Aono et al., 1999; Reynolds et al., 1996) , indicated that fibroblastic cells express preferentially isoform 1 (p120-1) while epithelial cells express preferentially isoform 2 (p120-2). Furthermore, the differential expression of the two different isoforms has been implicated in the regulation of cell motility , in line with the p120-1 isoform being upregulated in invasive tumor cells forming metastases. In our investigation of whole cell lysates the short p120-2 isoform was detected at elevated levels compared to the long p120-1 isoform in the epitheliallike cells such as COGA-1, COGA-5 and COGA-10 and in those with established cell-cell contacts as COGA-12 ( Figure 5 ). The mesenchymal p120-1 isoform was markedly upregulated in the lymph node metastasis cells COGA-5L and in the rounded-up cells COGA-2 and COGA-3. In SW 480 cells, the expression Figure 5 Expression levels of proteins in the adherens junction. Western blots of whole cell lysates were developed with mouse monoclonal anti-E-cadherin (AEC), anti-a-catenin, anti-b-catenin, anti-g-catenin and anti-p120 antibodies. Top band in p120 blots, variant p120-1, lower band, variant p120-2. To control for equal protein loading, blots were developed with mouse monoclonal anti-transferrin receptor antibody Functional characterization of low passage number colon carcinoma cells B Vé csey-Semjén et al of both p120-1 and-2 was significantly reduced, in accordance with previous observations , a similar down regulation was observed in COGA-8 cells ( Figure 5 ).
Mutation analysis for K-Ras and p53
The above results indicated that the panel of cell lines studied here showed a large diversity with respect to morphology, status of epithelial polarity versus degree of dedifferentiation and expression pattern of several junctional proteins. Nevertheless, these diverse phenotypes were well conserved between primary tumors and their derived cell lines. It was therefore of interest to determine whether or not the known mutations found in genes in colon carcinoma would exhibit a similar diversity and perhaps bear relationships to the phenotypic and protein expression changes observed. K-ras acquires oncogenic activity through point mutation(s) at particular positions, an event related to the initiation of carcinogenesis in model systems. The most common mutation in K-ras, at position 12, was previously observed in as much as 40% of primary colon tumors . We found K-ras mutations in cell lines COGA-2, COGA-5 and COGA-5L (37.5%). In cultured COGA-5 cells, derived from the primary tumor, K-ras was mutated at position 13 on one allele (see Table 2 ), while in cultured cells from a lymph node metastasis of the same patient (COGA-5L), it was mutated at position 12 on both alleles (Table 2, tot. 12). COGA-2 carried a mutation at position 12 in one allele. Mutations in p53, disrupting its tumor suppressor function, are frequent in multiple human cancers and have also frequently been identified in colorectal cancers, usually together with K-ras mutations. In our cell lines, p53 mutations were observed together with K-ras mutations in the same three, out of eight, cell lines (COGA-2, COGA-5 and COGA-5L (37.5%), indicating a possible requirement for both mutations to occur in the same tumor.
E-cadherin mutation analysis
In both COGA-2 and COGA-3 cells no full length Ecadherin protein could be detected by Western blotting (see above). Using reverse transcription PCR (RT -PCR), no E-cadherin cDNA fragments could be detected in COGA-2 cells, suggesting expression of the gene has been downregulated. Therefore, this cell line was not analysed for E-cadherin mutations by RT -PCR and direct sequencing. In the COGA-3 cell line RT -PCR and agarose gel electrophoresis of the cDNA revealed, in addition to the wild type fragment, also a shorter PCR product (data not shown). Sequencing of the shorter cDNA fragment identified a deletion of the last 37 nucleotides from exon 12 (nucleotides 1994 -2030, E-cadherin sequence Z13009 in GenBank). This deletion resulted in a frame shift and is predicted to generate a stop codon, 18 nucleotides after the deletion. To determine whether this deletion was also present in the cell line's gene, genomic DNA spanning exon 12 was amplified and sequenced. We found a heterozygous C to T transition in codon 634 (GCG to GTG) that would result in an amino acid change (A634V) but more importantly could activate a new splicing site resulting in the outof-frame deletion. Sequencing of the genomic DNA isolated from the respective primary tumor (tumor-3) revealed the same heterozygous C to T transition as was detected in the COGA-3 cell line indicating that the mutation was already present in the primary tumor.
Another E-cadherin mutation was identified in this cell line: deletion of a C nucleotide in exon 5 from the stretch of 5 C nucleotides from codons 200 and 201. To clearly identify this deletion, cDNA was amplified and cloned into plasmid vectors. Ten clones were selected and after plasmid purification the inserts were sequenced. Half of the sequences showed the normal sequence and the other half showed a clear deletion of a C nucleotide (data not shown). Since no full length E-cadherin protein was detectable (see Figure 5 ), the two structural mutations most likely affected different alleles, resulting in the loss of full-length E-cadherin protein in cell line COGA-3.
To confirm our presumption that E-cadherin was mutated on both alleles in the COGA-3 cells, which should result in small, secreted N-terminal fragments of E-cadherin in the medium, we performed immunoprecipitation and Western blot analysis of the culture medium. The presence of the larger, *75 kD fragment, occurring after the activation of the new splicing site, was confirmed by immunoprecipitation with the Nterminal specific HECD-1 antibodies from the cell culture medium. The small N-terminal peptide, presumably transcribed from the other allele, could not be detected with the HECD-1 antibody, reacting with an epitope, located in exon 8 (codons 337 -379) (Becker et al., 2002) , since the one base pair deletion mutation resulted in a stop codon before exon 8. It is likely that such a small protein fragment may be unstable.
b-catenin mutation analysis
To search for b-catenin mutations, sequences spanning exon 3, in which all mutations known so far have been identified, were amplified by RT -PCR and sequenced from all cell lines. We detected one mutation in bcatenin from the COGA-3 cell line (data not shown). This mutation resembled a homozygous C to T transition affecting codon 45, resulting in an amino acid change (S45F) that is predicted to affect phosphorylation of b-catenin by GSK-3b. Hence such a mutation should prevent b-catenin from degradation by the proteasome pathway. To our surprise, the bcatenin protein was present at rather low levels in the COGA-3 cells (Figure 5 ), despite the stabilizing mutation. According to immunostaining, the protein was abundantly present in the nucleus, suggesting that the stabilized b-catenin protein may be difficult to extract from the cells in our subsequent biochemical analyses. (Figure 6b ).
The b-catenin/Tcf/LEF signaling pathway is activated in several of the cell lines
The APC mutations present in the COGA cell lines implicated an activated b-catenin/Tcf/LEF signaling pathway. In addition, those COGA cell lines lacking APC mutations (COGA-3, COGA-10) carried mutations in E-cadherin/b-catenin and/or showed strong mislocalization of those proteins. This suggested that b-catenin might be constitutively activated in several of the colon carcinoma cell lines presented here. Analysis of b-catenin/Tcf/LEF transcriptional activation using the TOPFLASH luciferase assay revealed that the fully 'unpolarized' SW 480 cells exhibited an approximately 100-fold higher activity than Caco 2 cells, employed as 'polarized' control. Among the studied colon cancer cell lines we observed the highest levels of TOPFLASH luciferase activity in COGA-2 and COGA-10 cells (21/ 22% of positive control). In COGA-2 cells the APC gene was truncated in both alleles, resulting in a fragment of approximately half size of the intact fragment (see Figure 6a ,b). The relatively high TOPFLASH activity found in the COGA-10 cells was consistent with the nuclear accumulation of both b-catenin and plakoglobin, suggesting that other events than APC mutations had activated b-catenin/Tcf/LEF signaling in these cells. A lower degree of TOPFLASH activity was detected in COGA-3, COGA-5L and COGA-8 cells (Figure 7a ). Loss of E-cadherin expression as a consequence of mutations may be the reason for the slight increase in TOPFLASH activity in COGA-3 cells despite no mutation in APC was found (Figure 7b ). The TOPFLASH activity of the lymph node metastasis COGA-5L cells was about 16-fold higher when compared to COGA-5 cells, isolated from the primary tumor, although these contained conserved APC truncation mutations. Again, this could be explained by the altered, more mesenchymal morphology of these cells as compared to the primary tumor. Interestingly, both COGA-10 and COGA-5L cells expressed increased amounts of vimentin (Figure 2 ).
Cell invasiveness correlates with activation of b-catenin/Tcf/LEF signalling
Our results on mutations in oncogenes and in the tumor suppressor gene APC, up-regulation of EMT marker proteins and mislocalization and/or downregulation of junctional proteins pointed towards enhanced migratory properties of the cell lines. This was addressed by seeding the cells onto Matrigel coated filter cups and measuring their ability to cross these filters, as a measure of their in vitro invasive properties. After 68 h incubation time less than 10% of Figure 6 Non-radioactive protein truncation test identified APC truncation mutations. A 2-kb fragment of the APC exon 15, encompassing codons 1028 -1700, which include the mutation cluster region, was amplified using a T7-modified primer. An aliquot of the T7-modified PCR product is transcribed into capped RNA that is subsequently translated into biotin-labeled proteins using a reticulocyte lysate system containing charged lysine-tRNA. The biotin-labeled peptides were visualized by Western blotting. Abnormal peptides are marked by white and black asterisks. control Caco 2 and the polarized epithelial COGA-1 cells migrated through the Matrigel coated filters, while the other epithelial-like cell lines COGA-5 and COGA-10 had slightly increased migration levels (19.7 and 34.6% respectively). COGA-8 cells, showing a mesenchymal phenotype, had the strongest invasive character (68.5%), very close to our positive control, the SW 480 cells, followed by the rounded up cells COGA-2 (60.6%) and COGA-3 (33.9%) (Figure 8a ).
In general, the results on b-catenin/Tcf/LEF activation, as measured by the TOPFLASH assay, correlated well with an in vitro invasive phenotype observed in the Matrigel invasion assay. The cell lines COGA-1, -5 and -12 being lowest in the TOPFLASH assay also showed the lowest migration ability.
The isolated cell lines induce tumor growth in mice
Finally, we tested the tumorigenicity of six out of eight cell lines (COGA-1, COGA-2, COGA-3, COGA-5, COGA-5L and COGA-12) by their capacity to grow in mice with multiple immunodeficiencies. All mice injected with 10 7 cells developed tumors with the exception of COGA-5 cells that did not induce tumor growth at the concentrations used (summarized in Table 2 ). All mice developed tumors after injection with 10 5 COGA-1 or COGA-3 cells. Three out of four mice developed tumors after injection with 10 6 COGA-2 or COGA-5L cells while only two animals out of four injected with the same concentration of COGA-12 cells developed tumors. When we injected 10 7 cells, five out of six cell lines used in the experiment induced tumor growth in all animals. To rule out that the injected cells indirectly caused the growth of donor origin tumors, similar doses of the same cells were injected in mice after g-irradiation in a control experiment. As expected, this treatment did not lead to tumor formation in any of the cases.
Discussion
The study presented here was initiated due to the scarcity of well-characterized, low passage cell lines to investigate colorectal carcinogenesis. In other epithelial lineages, in vitro derived cell lines corresponding to their tumors of origin have already been demonstrated (Altorki et al., 1993; Oh et al., 1999) . Wistuba et al., published an extensive comparison of 18 human breast -as well as 12 human lung cancer cell lines (Wistuba et al., 1998 (Wistuba et al., , 1999 and their corresponding tumors. They observed an excellent correlation between the cell lines and their tumor tissue of origin by comparing morphology, ploidy and LOH (PCR -LOH) analysis, while no analysis for epithelial/mesenchymal markers was performed. Similarly, molecular analysis of eight human gastric cancer cell lines, established in Japan between 1977 -1991, showed enhanced telomerase activities and alterations of tumor suppressor genes, oncogenes, cell cycle regulatory genes and genetic alterations of cell adhesion molecules. These cell lines were established during a long time period, precluding direct comparison with parental tumor tissue. Nevertheless, these cell lines represent the general molecular characteristics of primary gastric cancer tissues (Yokozaki, 2000) . While these studies established that in vitro cancer cell lines resembling their parental tumors can be isolated, other studies reported deviations. In glioma cell lines homozygous p16 deletions were found, while no p16 alterations were found in the corresponding tissues (Hartmann et al., 1999) . Furthermore, deviations in hypermethylation genes in cancer were reported (Smiraglia et al., 2001) . All these investigations depicted strictly the status quo of the cell lines and the original tumors, respectively, but not the possible pathways leading to malignant growth, though the changes described indicated the activation of some of the known pathways.
Here we report the detailed characterization of eight novel, low passage colorectal cancer cell lines. The alterations in junctional proteins, mesenchymal markers and deregulated signaling cascades found improve our knowledge about mutations and pathway activation in human cancers. The primary tumors, from which the cell lines originated, showed a high degree of morphological heterogeneity and marker gene expression. This variability in genotype and phenotype was fully reflected in our cell lines. Three of the eight cell lines showed an epithelial-like morphology, three grew in multilayers and two were rounded up and loosely attached to the support. Despite this widely different morphology, all cell lines were of epithelial origin, since they expressed the epithelial cytokeratins 8, 19 and 20. These results suggest that low passage cell lines are indeed available from tumors of widely different types.
A similar variability in phenotypes was described by Oh et al. (1999) . These authors reported colorectal carcinoma cell lines growing either as adherent monolayers or as non-adherent and floating aggregates. Primary tumors that were neither mucinous nor desmoplastic gave rise to both floating and attached tumor cells.
Oncogene/tumor suppressor gene mutations and Wnt signaling
In *85% of colorectal cancers, APC was shown to be lost or inactivated (Miyoshi et al., 1992) (Jen et al., 1994) . This is thought to be an initial step, which activates Wnt signaling, leading to nuclear accumulation of b-catenin and activation of Tcf/LEF-dependent gene transcription. In accordance with this observation, we found APC aberrations in six out of the eight cases studied. Likewise Wnt signaling was elevated in five of the cell lines. In two cell lines showing elevated Wnt signaling, COGA-3 and COGA-10, no mutations in the mutational cluster region (MCR) could be identified in the lines and their corresponding parental tumors. However, in COGA-3 cells E-cadherin and b-catenin mutations were found (see below). In contrast, COGA-10 cells, showing strong accumulation of both bcatenin and plakoglobin in the nucleus and activation of b-catenin/Tcf/LEF signaling, lacked truncation mutations in the MCR of APC as well as mutations in the E-cadherin or b-catenin genes.
The initial APC mutations are usually followed by a series of somatic mutations in the p53, the K-ras and the DCC genes . Mutations in p53, disrupting its tumor suppressor function, are frequent in multiple human cancers including colorectal cancers. K-ras acquires oncogenic activity through point mutation(s) at particular positions, an event related to initiation of carcinogenesis in model systems. The most common mutation in K-ras, at position 12, was previously observed in as much as 40% of primary colon tumors . p53 mutations coupled with K-ras mutations were found in cell lines COGA-2, COGA-5 and COGA-5L (Table 2) . It is not an unusual event that both K-ras codon 12 and p53 mutations appear in the same tumor, and these tumors have worse prognosis than tumors with other mutation combinations (Pricolo et al., 1996) . On their own, Ras mutations may not be sufficient for tumor progression and metastasis, leading even to spontaneous growth arrest in transfected cells (Jones et al., 2000) . Therefore, the coupling between the two mutational events could lead to tumor progression, combining loss of DNA stability checkpoint control and activation of MAPK and PI3K signaling pathways, controlled by p53 and ras respectively. This may be the case of the COGA-2 and COGA-5 cells. The shift of the point mutation in Kras, observed at position 13 in COGA-5 cells, derived from the primary tumor, to position 12, found in COGA-5L cells, derived from the lymph node metastasis, strengthens the previous observation that mutation at codon 12 has a dominant effect Guerrero et al., 2000) . Our observations are thus in line with the idea that cells harboring codon 12 mutations may have a growth advantage over those with initial mutations at codon 13, and that codon 12 mutations may promote tumor metastasis.
E-cadherin mutations
Mutations of the E-cadherin gene have only rarely been detected in colorectal cancers, although such mutations are characteristic for diffuse type gastric and lobular breast carcinomas (Berx et al., 1998) . Efstathiou et al. (1999) reported that only 3% of the colorectal carcinoma cell lines analysed harbored E-cadherin mutations. Interestingly, we found E-cadherin mutations in one cell line, COGA-3, in which we did not observe an APC mutation in the MCR, suggesting that an E-cadherin defect may be an alternative to APC inactivation. Among the mutations reported by Efstathiou et al. (1999) , deletion of a single bp (codon 126) from a stretch of 6 C nucleotides resulting in a frame shift was found in a replication error-positive cell line. In COGA-3, a cell line with chromosomal instability, a similar 1 bp deletion in exon 5 was found to remove one C nucleotide from a stretch of 5 Cs in codons 200/201. Both alleles in the COGA-3 cell line were found to express mutant Ecadherin mRNA resulting in complete protein loss of this major cell-to-cell adhesion molecule. As a consequence of these new mutations, COGA-3 cells are rounded up and devoid of cell-cell contacts, showing that the original function of E-cadherin is impaired. One of the Ecadherin mutations resulted in small, secreted, Nterminal fragments. Such fragments may interfere with the normal function of full length E-cadherin, as
Functional characterization of low passage number colon carcinoma cells B Vé csey-Semjén et al was previously described (Wheelock et al., 1987) . Unexpectedly, we were able to detect E-cadherin immunoreactivity in the nuclei of the cells using an antibody that reacts with the C-terminus. Possibly, this mutation-induced splicing site may not be used exclusively and small amounts of full-length E-cadherin protein may still be synthesized. As the amount of Ecadherin is insufficient to establish cell-cell contacts and form adherens junctions, it may be degraded in the cytosol and its cytoplasmic part, bound to b-catenin, translocated into the nucleus. Similarly nuclear Ecadherin has recently been reported in Merkel cell carcinomas (Han et al., 2000) and in one mammary carcinoma (Keller et al., 1999) . Once in the nucleus, the E-cadherin cytoplasmic portion could block interaction of b-catenin with the transcription factors LEF-1 and Tcf-4, since b-catenin binding is mutually exclusive to either E-cadherin or LEF-1 (Sadot et al., 1998) . This mechanism of action would explain the relatively low transcriptional activity evaluated by the TOPFLASH signal observed in the COGA-3 cells. Previously, the intracellular accumulation of b-catenin was reported as a consequence of N-terminal mutations in Ser 33 and Ser 45 , which rendered it insensitive to phosphorylation at the above mentioned sites (Morin et al., 1997; Rubinfeld et al., 1997) . In our COGA-3 cells, the stabilized b-catenin mutant S45F may play a significant role in the b-catenin/ Tcf/LEF signal transduction pathway.
Although lacking detectable mutations in E-cadherin, COGA-2 cells expressed only extremely low amounts of this protein, possibly insufficient to establish the intercellular E-cadherin 'zipper'. After proteolysis, the cytoplasmic tail of E-cadherin ends up in the nuclei, presumably through a similar mechanism as depicted for COGA-3 cells. E-cadherin transcription may be blocked in COGA-2 cells by the transcription factors Snail (Batlle et al., 2000; Cano et al., 2000) , SIP1 (Comijn et al., 2001) or E12/E47 (Perez-Moreno et al., 2001) through their direct binding to E boxes in the E-cadherin promoter. The much higher amount of b-catenin expressed in COGA-2 cells than in COGA-3 cells had the expected effect on the resulting TOPFLASH reporter activity (3.5 times higher in COGA-2 than in COGA-3 cells, see Figure 8a ).
Further, diverse cellular phenotypes of the cell lines described
The acquisition of a mesenchymal phenotype, mislocalized adherens junction proteins (Table 2) and increased cell migratory properties, all imply that the colon epithelial cells COGA-8 had undergone a process resembling EMT. The high mobility of the COGA-8 cells, observed using Matrigel-coated filters, may involve production and/or activation of proteases. Both matrilysin and the matrix metalloproteinase MMP-7 were recognized as target genes in the Wnt signal transduction pathway and observed at elevated levels in colon cancer cells (Brabletz et al., 1999; Crawford et al., 1999) . Furthermore, stromelysin-1, which may play a role in the degradation of Ecadherin, was found to be upregulated in malignant tissues and therefore expected to play a role in EMT (Lochter et al., 1999) .
COGA-1 cells were isolated from a patient with HNPCC (Table 1) . Microsatellite (MIN) instability was previously observed in HNPCC patients' material (Yamamoto et al., 2001 ) and we found it in the COGA-1 cells. These cells did not show chromosomal instability, formed polarized monolayers on filter supports, had properly localized junctional proteins, were non-invasive on Matrigel-coated membranes and displayed low transcription activity as measured by the TOPFLASH assay (Table 2 ). In COGA-1 cells we found APC truncated on one allele. However, despite the ordered, epithelial morphology, COGA-1 cells were clearly tumorigenic in nude mice. All other cell lines showed chromosomal instability. We are presently investigating if autocrine growth factor or cytokine signaling pathways are involved in the tumorigenicity of the COGA cell lines.
Currently, the use of low-passage cell lines from primary, well differentiated tumors in cancer research is restricted by their initially slow growth rate and the still inefficient ways to establish such cells in culture without selecting for further mutations. In most cases, culturing these cells for many passages during extended time periods selects for faster growing cell subpopulations, progressively accumulating alterations in genotype and also in phenotype. One advantage of our study was that we avoided culturing the cells for longer time periods than necessary. Alternative approaches to generate genetically defined human tumor cells by introduction of known oncogenes/ tumor suppressors into diploid fibroblasts and mammary epithelial cells have been described (Elenbaas et al., 2001; Hahn et al., 1999) . However, these cells are likely to have accumulated additional mutations since oncogenes inducing genetic instability were introduced at the beginning of the experiments and the initially diploid cells got highly aneuploid during their establishment. Furthermore, these cells do not display the features of human cancers. Ideally, one would like to establish carcinoma cell cultures from each patient in parallel with healthy tissue samples (as reviewed by Masters, 2000) . Until the necessary methods are developed, we are restricted to the current cell culture models. This study describes one approach how one could ensure that these models remain close to the primary tumors they were derived from.
In conclusion, our results establish that both the eight cell lines described and their parental tumors showed far more diverse alterations than expected from the classical colon carcinoma progression model . Since many of the tests establishing this diversity were difficult or impossible in primary tumor material, the cell lines were instrumental to unravel this surprising multitude of tumor cell phenotypes, keeping in mind that our low PN cell lines were of relatively homogenous origin with respect to grading and staging of the primary tumors they were derived from. The fact that our COGA cell lines faithfully reflected all characteristics of the tumors analysed suggests that analyses like the one presented here could lead to better understanding of the large diversity of colon carcinomas occurring in patients. In this respect we feel that these new cell lines are an exquisite tool for the understanding of colorectal carcinogenesis.
Materials and methods

Isolation and establishment of colorectal carcinoma cell lines
Tumor samples were obtained from three hospitals after approval of the study by the local ethical committee and with written, informed consent from all patients. Immediately after surgery, tumors were evaluated by a pathologist and tumor material not required for histopathologic diagnosis was either snap frozen in liquid nitrogen or further processed to establish cell lines as follows. Connective tissue was removed from the tumor specimens under a laminar airflow hood and samples were incubated with RPMI 1640 medium (Gibco BRL) supplemented with 200 U/ml Penicillin, 200 mg/ml Gentamycin, 200 mg/ml Streptomycin and 5 mg/ml Amphotericin B (Gibco BRL) for 15 min, transferred into transport medium (above medium with 1/2 of antibiotics) and transported to the research lab on wet ice within 24 h. Upon arrival, the tumor specimen were washed 2 -3 times with transport medium, incubated for another 20 min in transport medium, taken up with complete culture medium (RPMI 1640 supplemented with heat-inactivated 10% fetal calf serum (FCS), 1% Lglutamine, 1% Na-pyruvate, 50 mg/ml Gentamycin (Gibco BRL) and dissected in 14, 5 cm Petri dishes into small pieces of 53 mm using a Cutfix 20 disposable sterile scalpel (Braun). Cells were released from connective tissue by gently passing them through a cell dissociation sieve (mesh 40, Sigma S0770) and a 70 mm cell strainer (Falcon). After washing three times with complete medium, viability was determined by trypan blue exclusion. Primary colorectal carcinoma cells were seeded at a density of about 3610 4 cells/cm 2 into appropriately sized tissue culture flasks containing complete culture medium, sometimes containing 100 U/ml Penicillin, 100 mg/ml Streptomycin and 2.5 mg/ml Amphotericin B. Following adhesion of the cells, medium was replaced approximately every 3 -4 days, depending on the cells' growth rate. When 80% confluency was reached, culture medium was removed. Cells were washed once with phosphate buffered saline (PBS) and harvested by trypsinization. Residual trypsin was removed by washing with 10% FCS-containing medium followed by seeding 10 5 cells into new tissue culture flasks. Addition of antibiotics to the cell culture medium was discontinued as soon as cell lines were established and growing without noticeable microbial contamination. Cell lines were expanded to generate small cell banks ('stocks') at passage numbers between 1 and 4 (after primary culture). Absence of bioburden (bacteria, mycoplasma) was confirmed by standard testing procedures.
Caco 2 cells were cultured as previously described (Chantret et al., 1994) . SW 480 cells were grown in DMEM supplemented with 10% FCS (Bio-Withaker), 1% Penicillin/ Streptomycin and 1% L-glutamine (both from Gibco BRL).
Antibodies, immunofluorescence and confocal microscopy
Cells cultured on glass coverslips or porous filter supports (Costar, pore-size 0.4 mm; to allow polarization) were processed for indirect immunofluorescence and analysed on a Leica TCS NT confocal microscope as described previously (Oliferenko et al., 1999; Wunderlich et al., 2001) .
Mouse monoclonal antibodies were purchased against vimentin (M7020, Dako); fibronectin (F-0916, Sigma); connexin-43 (Transduction Laboratories). Anti-E-cadherin antibodies against the N-(HECD-1 and SHE 78-7, Takara Shuzo Co.) or C-terminal part (Anti-E-cadherin (AEC), clone 36, Transduction Laboratories) were purchased together with goat polyclonal antibodies against human E-cadherin (N-20, Santa Cruz Biotechnology). Mouse monoclonal A6 (clone 14, Transduction Laboratories) against b-catenin; mouse monoclonal antibodies against a-catenin (clone 5), plakoglobin (gcatenin) (clone 15), and p120 were purchased from Transduction Laboratories. Rabbit polyclonal antibodies against occludin were kindly provided by Dr Karl Matter. Rat monoclonal antibodies against ZO-1 (MAB 1520) were purchased from Chemicon and rabbit polyclonal antibodies from Zymed. Rabbit polyclonal antibodies against b-catenin (SAT 101) were generated in our laboratory.
Immunohistochemical analysis
Five mm sections of routine formaline fixed and paraffin embedded material from colon cancer patients, confirmed to express mutant E-cadherin and/or b-catenin messenger RNA, were analysed. After microwave-based antigen retrieval with citric acid pre-treatment (Shi et al., 1991) , sections were incubated in 1% hydrogen peroxide for 15 min to block endogenous peroxidase activity. For detection of the specific immunoreactivity, the specimen was incubated with monoclonal antibodies against E-cadherin and b-catenin at RT for 2 h. In addition, the HECD-1 monoclonal antibody against E-cadherin (Alexis GmbH) was used. Bound antibodies were detected using the avidin-biotin-complex (ABC) peroxidase method (ABC Elite Kit, Vector). Final staining was developed with the Sigma FAST DAB peroxidase substrate kit (Sigma). Haemalaun was used for counterstaining.
K-ras and p53 mutation analysis
A K-ras human oncogene specific fragment was PCRamplified using primer sequences chosen from the 5' noncoding region through 300 bp downstream from the initiation codon (Kahn et al., 1987) ; primer 1: 5'-AGGTGCGGGA-GAGAGGCCTGCTG-3', primer 2: 5'-CTGTTTTGTGTCT-ACTG-TTCTAGAAGG-3'. The resulting fragment of 412 bp was sequenced in both directions using the same primers. p53 specific cDNA fragments were PCR amplified with the 5' primer in exon 4 and the 3' primer in exon 9; primer 1: 5'-GGCTTCTTGCATTCTGG-3', primer 2: 5'-GGTTTCTTC-TTTGGCTGG-3'. Both alleles of the resulting 621 bp fragment, harboring the entire 'hot spot' region (Harris et al., 1986) , were sequenced (Kahn et al., 1987) .
E-cadherin sequence analysis
Sequences spanning the entire E-cadherin coding region were amplified in five overlapping fragments (A to E) using reverse transcription-polymerase chain reaction (RT -PCR) as previously described . The amplification products were purified by agarose gel electrophoresis and directly sequenced using internal primers. The primer pairs used to amplify the complete coding region were as follows: (nucleotide (nt) positions refer to an E-cadherin sequence deposited in the EMBL/GenBank Data Libraries, accession number Z13009; the A of the ATG of the initiator Met codon is denoted as nt+1): fragment A (nt 72 to +832), primer A1: 5'-CCATGGGCCCTTGGAGCCGC, A2: 5'-CTG GAA GAG CAC CTT CCA TGA C; fragment B (nt 649 -1378), primer B1: 5'-ACA GAG CCT CTG GAT AGA GAA CGC, B2: 5'-CCACATTCGTCACTGCTACG; fragment C (nt 1220 -1686), primer C1: 5'-CAG CGT GGG AGG CTG TAT ACA C, C2: 5'-TGT GTA CGT GCT GTT CTT CAC; fragment D (nt 1483 -2170), primer D1: 5'-GTG TCC GAG GAC TTT GGC GTG, D2: 5'-TCA GAA TTA GCA AAG CAA GAA TTC C; fragment E (nt 2077 -2687), primer E1: 5'-GGC GTC TGT AGG AAG GCA CAG, E2: 5'-CCA GCA CAT GGG TCT GGG. To be able to identify exactly the one nucleotide deletion mutation in the COGA-3 cell line, the corresponding PCR fragment spanning the mutation was cloned. Ten clones were selected and the DNA sequenced.
b-catenin sequence analysis
A b-catenin cDNA fragment corresponding to exon 3 was amplified by PCR and sequenced. PCR amplification was performed in a final volume of 25 ml containing 2 ml of cDNA (1 : 10 diluted), 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 , 0.01% (w/v) gelatin, 200 mM dNTP, 0.4 mM of each primer, 1.25 U Taq polymerase (Perkin-Elmer/Cetus). The PCR conditions consisted of 1 cycle at 958C for 5 min followed by 40 cycles at 958C for 1 min, 568C for 1 min, and 728C for 1 min 30 s. The primers used for b-catenin amplification were as follows: forward primer 5'-ACA ACT GTT TTG AAA ATC CA-3', reverse primer: 5'-TTC TTG GTT GCC ATA AGC TA-3'. PCR amplified cDNA fragments were purified using the QIAquick gel extraction kit (Qiagen). Sequencing of the purified fragments was performed with the same primers as for PCR amplification using the Big Dye Sequencing Kit (Applied Biosystems). Samples were separated on a denaturing polyacrylamide gel in an automated sequencing system (ABI 377, Applied Biosystems).
APC mutation detection by non-radioactive protein truncation test (nrPTT)
A 2-kb fragment of the APC exon 15, encompassing codons 1028 -1700, which includes the mutation cluster region, was amplified using the T7-modified primer apc15eT7 (5'-GGA TCC TAA TAC GAC TCA CTA TAG GAA CAG ACC ACC ATG CTT AAA TAT TCA GAT GAG CAG TTG AA) and primer apc15j3 (5'-GAG CCT CAT CTG TAC TTC TGC) according to the PCR protocol described in van der Luijt et al. (1994) . The non-radioactive protein truncation test (nrPTT) was performed as previously described (Becker et al., 1996) with some modifications. Briefly, 1 mg of the T7-modified PCR product, without further purification, was transcribed into capped RNA that was subsequently translated into biotin-labeled proteins using a reticulocyte lysate system containing charged lysine-tRNA (Roche) and detected on SDS polyacrylamide gels as described (Becker et al., 1996) .
Immunoprecipitation and immunoblotting
Total lysates were prepared and analysed by Western blotting as described (Wunderlich et al., 2001; Oliferenko et al., 2000) .
For immunoprecipitation of the E-cadherin/catenins adherens junctional complex proteins, cell lysates (*6610 7 cells) were pre-cleared by incubation with 200 ml of GammaBind G (Pharmacia) beads for 45 min at room temperature followed by incubation on ice. Equal amounts of total proteins were incubated overnight with anti-E-cadherin specific antibodies AEC and SHE at 48C, followed by incubation with Protein G beads and washed and eluted from beads. Proteins were detected in Western blots by specific monoclonal antibodies against the different protein components of the complex.
For isolation and detection of the secreted, N-terminal fragment of E-cadherin, 100 ml of culture medium from cells COGA-2 and COGA-3 were collected from 4 days-old culture. The medium was concentrated in Centriprep-30 concentration cups (Amicon) in the presence of protease inhibitors (Pefablock Ò , Roche) and incubated with HECD-1 (1 : 500) antibodies over night at 48C. As a control, AEC (1 : 2500) monoclonal antibodies were used. The antigenantibody complex was incubated with GammaBind Plus Sepharose (Pharmacia) for 50 min on a rotation-wheel and 3 h on ice. Beads were collected, washed and the proteins eluted by boiling in 10 ml of SDS-loading buffer. The Nterminal E-cadherin fragment was detected using goat polyclonal anti-human-E-cadherin antibodies.
Analysis of microsatellite instability
DNA was isolated from paraffin-embedded tumor and nonneoplastic colon mucosa and microsatellites were amplified essentially as described (Dietmaier et al., 1997) . Cy5-labeled primers were used to amplify the following gene loci: D2S123, BAT25, BAT26, D2S136, D3S1611S, D5S404, D8S255, D13S153, D17S787, D18S34, D20S100, TP53. The PCR-products obtained were analysed on an ALF-DNA Sequencer (Amersham Pharmacia Biotech, Freiburg, Germany).
Cytogenetic investigations
The cell lines were grown in conditioned medium (NCM) and harvested after 3 -14 days. Metaphase chromosome spreads were prepared and G-banded according to standard procedures.
Spectral karyotyping
Slides were freshly prepared from cell pellets stored in fixative. The slides were fixed in methanol: acetic acid (3 : 1) for 40 min and in acetone for 10 min, and then dehydrated through an alcohol series and air-dried. After proteinase K treatment (3 ml stock solution (2 mg/ml), Boehringer 161519) for 2 -8 min, the slides were denatured at 728C in 60% formamide in 26SSC pH 7 for 60 s, dehydrated through an ice-cold alcohol series, and air-dried. The multi-chromosome paint probe was applied according to the manufacturer's instructions (Applied Spectral Imaging, ASI, Migdal Ha'Emek, Israel). The probe was denatured in 758C for 7 min and preannealed at 378C for 1 h. Ten ml of the denatured SKY TM mixture was added to the denatured chromosome slides, covered by 22622-mm coverslips, and sealed with rubber cement. The slides were then incubated for 48 h at 378C in a humidified chamber and washed 365 min in 50% formamide/26SSC pH 7 at 458C and 265 min in 16SSC at 458C. Probe detection was carried out according to the ASI protocol, after which the slides were mounted and counterstained with DAPI/antifade solution. For each case, between nine and 14 metaphase cells were captured with an SD200 Spectra cube system (ASI) connected to a Zeiss Axioscop fluorescence microscope with a triple bandpass optical filter and analysed using the SKY view software (ASI).
Transient transfection and transactivation assay
Transactivation assays were performed with all adherent cell lines as well as SW 480 cells used as positive and Caco 2 cells as negative controls as described (Vietor et al., 2001) . LEF-1 transcriptional activity assays were with pTOPFLASH and pFOPFLASH constructs, respectively (van de Wetering et al., 1997; Vietor et al., 2001) . For normalization of transfection efficiency the pGK-Geo plasmid, encoding b-galactosidaseNeo-fusion protein, was co-transfected with the reporter (Vietor et al., 2001) .
Cell invasion assay
To determine the invasive properties of each cell line 4610 5 cells were seeded in 0.5 ml serum free medium supported with 0.1% bovine serum albumin (BSA) onto BD BioCoat TM growth factor reduced MATRIGEL TM coated invasion chambers of a size of 6.4 mm (Becton & Dickinson). As chemoattractant 0.75 ml medium with 10% FCS was used in the plate well. As controls BD BioCoat control cell culture inserts were used. Cells were grown for 68 h following supplier's instructions. Cells on the bottom side of the membrane were counted without staining in light microscope or after staining with rhodamine-phalloidin in fluorescence microscope. The per cent of invasion was determined as follows:% Invasion=Mean # of cells invaded through GFR Matrigel membrane6100/mean # of cells migrated through control membrane.
Tumorigenicity assay
To investigate the tumorigenicity of the isolated colorectal carcinoma cell lines, cells were grown as described above, harvested and washed with PBS. Cell suspensions of 10 7 , 10 6 , 10 5 , 10 4 and 10 3 cells/ml were prepared in Ringer's solution.
Two male and two female 5 to 6-weeks-old athymic Hsd: NMRI-nu/nu mice (Harlan) per cell line and cell concentration were injected subcutaneously with 200 ml of cell suspension at one site/mouse. Tumor diameters were measured once a week with a caliper. Animals were sacrificed when tumors had grown to sizes of *3000 mm 3 .
Abbreviations aa, amino acid; APC, adenomatous polyposis coli; bp, base pair; DMEM, Dulbecco's Modified Eagle Medium; FCS, fetal calf serum; LEF-1, leukocyte enhancing factor; LOH, loss of heterozygosity; nt, nucleotide; PCR, polymerase chain reaction; TCF, T-cell factor; HNPCC, hereditary nonpolyposis colon cancer.
